A highly pathogenic simian/human immunodeficiency virus effectively produces infectious virions compared with a less pathogenic virus in cell culture

por Iwanami, Shoya, Kakizoe, Yusuke, Morita, Satoru, Miura, Tomoyuki, Nakaoka, Shinji, Iwami, Shingo
Publicado 2017

Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors

por Tatematsu, Daiki, Akao, Marwa, Park, Hyeongki, Iwami, Shingo, Ejima, Keisuke, Iwanami, Shoya
Publicado 2023

Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection

por Kim, Kwang Su, Iwanami, Shoya, Oda, Takafumi, Fujita, Yasuhisa, Kuba, Keiji, Miyazaki, Taiga, Ejima, Keisuke, Iwami, Shingo
Publicado 2021

Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study

por Ejima, Keisuke, Kim, Kwang Su, Bento, Ana I., Iwanami, Shoya, Fujita, Yasuhisa, Aihara, Kazuyuki, Shibuya, Kenji, Iwami, Shingo
Publicado 2022

Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model

por Ejima, Keisuke, Kim, Kwang Su, Iwanami, Shoya, Fujita, Yasuhisa, Li, Ming, Zoh, Roger S., Aihara, Kazuyuki, Miyazaki, Taiga, Wakita, Takaji, Iwami, Shingo
Publicado 2021

Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection

por Kumata, Ryuichi, Iwanami, Shoya, Mar, Katrina B., Kakizoe, Yusuke, Misawa, Naoko, Nakaoka, Shinji, Koyanagi, Yoshio, Perelson, Alan S., Schoggins, John W., Iwami, Shingo, Sato, Kei
Publicado 2022

Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma

por Iwanami, Shoya, Kitagawa, Kosaku, Ohashi, Hirofumi, Asai, Yusuke, Shionoya, Kaho, Saso, Wakana, Nishioka, Kazane, Inaba, Hisashi, Nakaoka, Shinji, Wakita, Takaji, Diekmann, Odo, Iwami, Shingo, Watashi, Koichi
Publicado 2020

Estimation of the incubation period of COVID-19 using viral load data

por Ejima, Keisuke, Kim, Kwang Su, Ludema, Christina, Bento, Ana I., Iwanami, Shoya, Fujita, Yasuhisa, Ohashi, Hirofumi, Koizumi, Yoshiki, Watashi, Koichi, Aihara, Kazuyuki, Nishiura, Hiroshi, Iwami, Shingo
Publicado 2021

Designing isolation guidelines for COVID-19 patients utilizing rapid antigen tests: a simulation study using viral dynamics models

por Jeong, Yong Dam, Ejima, Keisuke, Kim, Kwang Su, Joohyeon, Woo, Iwanami, Shoya, Fujita, Yasuhisa, Jung, Il Hyo, Shibuya, Kenji, Iwami, Shingo, Bento, Ana I., Ajelli, Marco
Publicado 2022

Designing isolation guidelines for COVID-19 patients with rapid antigen tests

por Jeong, Yong Dam, Ejima, Keisuke, Kim, Kwang Su, Joohyeon, Woo, Iwanami, Shoya, Fujita, Yasuhisa, Jung, Il Hyo, Aihara, Kazuyuki, Shibuya, Kenji, Iwami, Shingo, Bento, Ana I., Ajelli, Marco
Publicado 2022

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2

por Kim, Kwang Su, Ejima, Keisuke, Iwanami, Shoya, Fujita, Yasuhisa, Ohashi, Hirofumi, Koizumi, Yoshiki, Asai, Yusuke, Nakaoka, Shinji, Watashi, Koichi, Aihara, Kazuyuki, Thompson, Robin N., Ke, Ruian, Perelson, Alan S., Iwami, Shingo
Publicado 2021

Revisiting the guidelines for ending isolation for COVID-19 patients

por Jeong, Yong Dam, Ejima, Keisuke, Kim, Kwang Su, Iwanami, Shoya, Bento, Ana I, Fujita, Yasuhisa, Jung, Il Hyo, Aihara, Kazuyuki, Watashi, Koichi, Miyazaki, Taiga, Wakita, Takaji, Iwami, Shingo, Ajelli, Marco
Publicado 2021

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro

por Shionoya, Kaho, Yamasaki, Masako, Iwanami, Shoya, Ito, Yusuke, Fukushi, Shuetsu, Ohashi, Hirofumi, Saso, Wakana, Tanaka, Tomohiro, Aoki, Shin, Kuramochi, Kouji, Iwami, Shingo, Takahashi, Yoshimasa, Suzuki, Tadaki, Muramatsu, Masamichi, Takeda, Makoto, Wakita, Takaji, Watashi, Koichi
Publicado 2021

Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir

por Torii, Shiho, Kim, Kwang Su, Koseki, Jun, Suzuki, Rigel, Iwanami, Shoya, Fujita, Yasuhisa, Jeong, Yong Dam, Ito, Jumpei, Asakura, Hiroyuki, Nagashima, Mami, Sadamasu, Kenji, Yoshimura, Kazuhisa, Sato, Kei, Matsuura, Yoshiharu, Shimamura, Teppei, Iwami, Shingo, Fukuhara, Takasuke
Publicado 2023

Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey

por Yoshida, Makoto, Kobashi, Yurie, Kawamura, Takeshi, Shimazu, Yuzo, Nishikawa, Yoshitaka, Omata, Fumiya, Zhao, Tianchen, Yamamoto, Chika, Kaneko, Yudai, Nakayama, Aya, Takita, Morihito, Ito, Naomi, Kawashima, Moe, Sugiura, Sota, Shibuya, Kenji, Iwami, Shingo, Kim, Kwangsu, Iwanami, Shoya, Kodama, Tatsuhiko, Tsubokura, Masaharu
Publicado 2022

Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study

por Iwanami, Shoya, Ejima, Keisuke, Kim, Kwang Su, Noshita, Koji, Fujita, Yasuhisa, Miyazaki, Taiga, Kohno, Shigeru, Miyazaki, Yoshitsugu, Morimoto, Shimpei, Nakaoka, Shinji, Koizumi, Yoshiki, Asai, Yusuke, Aihara, Kazuyuki, Watashi, Koichi, Thompson, Robin N., Shibuya, Kenji, Fujiu, Katsuhito, Perelson, Alan S., Iwami, Shingo, Wakita, Takaji
Publicado 2021

Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2

por Ohashi, Hirofumi, Hishiki, Takayuki, Akazawa, Daisuke, Kim, Kwang Su, Woo, Joohyeon, Shionoya, Kaho, Tsuchimoto, Kana, Iwanami, Shoya, Moriyama, Saya, Kinoshita, Hitomi, Yamada, Souichi, Kuroda, Yudai, Yamamoto, Tsukasa, Kishida, Noriko, Watanabe, Shinji, Hasegawa, Hideki, Ebihara, Hideki, Suzuki, Tadaki, Maeda, Ken, Fukushi, Shuetsu, Takahashi, Yoshimasa, Iwami, Shingo, Watashi, Koichi
Publicado 2022

Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments

por Akazawa, Daisuke, Ohashi, Hirofumi, Hishiki, Takayuki, Morita, Takeshi, Iwanami, Shoya, Kim, Kwang Su, Jeong, Yong Dam, Park, Eun-Sil, Kataoka, Michiyo, Shionoya, Kaho, Mifune, Junki, Tsuchimoto, Kana, Ojima, Shinjiro, Azam, Aa Haeruman, Nakajima, Shogo, Park, Hyeongki, Yoshikawa, Tomoki, Shimojima, Masayuki, Kiga, Kotaro, Iwami, Shingo, Maeda, Ken, Suzuki, Tadaki, Ebihara, Hideki, Takahashi, Yoshimasa, Watashi, Koichi
Publicado 2023

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

por Ohashi, Hirofumi, Watashi, Koichi, Saso, Wakana, Shionoya, Kaho, Iwanami, Shoya, Hirokawa, Takatsugu, Shirai, Tsuyoshi, Kanaya, Shigehiko, Ito, Yusuke, Kim, Kwang Su, Nomura, Takao, Suzuki, Tateki, Nishioka, Kazane, Ando, Shuji, Ejima, Keisuke, Koizumi, Yoshiki, Tanaka, Tomohiro, Aoki, Shin, Kuramochi, Kouji, Suzuki, Tadaki, Hashiguchi, Takao, Maenaka, Katsumi, Matano, Tetsuro, Muramatsu, Masamichi, Saijo, Masayuki, Aihara, Kazuyuki, Iwami, Shingo, Takeda, Makoto, McKeating, Jane A., Wakita, Takaji
Publicado 2021

A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19

por Miyazaki, Taiga, Hosogaya, Naoki, Fukushige, Yuri, Takemori, Sachiko, Morimoto, Shinpei, Yamamoto, Hiroshi, Hori, Makoto, Ozawa, Yoshihito, Shiko, Yuki, Inaba, Yosuke, Kurokawa, Tomoya, Hanaoka, Hideki, Iwanami, Shoya, Kim, Kwangsu, Iwami, Shingo, Watashi, Koichi, Miyazawa, Ken, Umeyama, Takashi, Yamagoe, Satoshi, Miyazaki, Yoshitsugu, Wakita, Takaji, Sumiyoshi, Makoto, Hirayama, Tatsuro, Izumikawa, Koichi, Yanagihara, Katsunori, Mukae, Hiroshi, Kawasuji, Hitoshi, Yamamoto, Yoshihiro, Tarumoto, Norihito, Ishii, Hiroshi, Ohno, Hideaki, Yatera, Kazuhiro, Kakeya, Hiroshi, Kichikawa, Yoshiko, Kato, Yasuyuki, Matsumoto, Tetsuya, Saito, Makoto, Yotsuyanagi, Hiroshi, Kohno, Shigeru
Publicado 2023